Aug 26 (Reuters) - Catalyst Pharmaceuticals Inc CPRX.O:
UPDATED- CATALYST PHARMACEUTICALS ANNOUNCES SETTLEMENT OF FIRDAPSE® (AMIFAMPRIDINE) PATENT LITIGATION WITH LUPIN PHARMACEUTICALS
CATALYST PHARMACEUTICALS INC - LUPIN TO DELAY GENERIC FIRDAPSE LAUNCH UNTIL FEB 25, 2035
CATALYST PHARMACEUTICALS INC - AND LUPIN TO TERMINATE PATENT LITIGATION BETWEEN CATALYST/SERB AND LUPIN